Web News Insider
-
How Jonas Salk’s 1954 Field Trial With 1.8 Million Children Led to the Polio Vaccine
NEW YORK, July 8 — 1.8 million children. That is the figure that matters from the 1954 field trial of Jonas Salk’s…
-
Pasteur’s 1881 Anthrax Vaccine Trial Was a Public Test, but the Vaccine Was Not What He Claimed
PARIS, July 8 — The mechanics of how a 19th-century chemist reshaped modern medicine are worth dissecting, because the story is less…
-
FDA Approves Breyanzi CAR-T Therapy for Relapsed Chronic Lymphocytic Leukemia
MANILA, July 7 — For families across the region watching loved ones battle blood cancers that keep returning, a new treatment option…
-
Rye pollen compounds’ structures unlocked after decades for cancer research
CHICAGO, July 7 — Nearly 30 years ago, researchers discovered two unusual molecules in rye pollen that appeared to slow tumor growth…
-
Tire chemical linked to new Alzheimer’s risk factor
SAN FRANCISCO — A study published in 2024 in the journal Environmental Health Perspectives has identified a chemical, 6PPD-quinone, as a potential…
-
Tire Pollution: A Growing Environmental Health Concern
WASHINGTON, July 7 — Tires are everywhere. Roughly 1.5 billion of them are produced annually worldwide, and when they wear down, the…
-
Northwestern Chemists Confirm Structures of Two Rye Pollen Molecules Tied to Tumor Clearance in Animals
MANILA, July 7 — A team of scientists has identified two new molecules from rye pollen that could one day change how…
-
CAR-T Sales in 2023: Gilead’s Yescarta Led at $1.5 Billion as Kymriah Slipped
ISLAMABAD, July 7 — The global market for CAR-T cell therapy, a personalized cancer treatment that reprograms a patient’s own immune cells…
-
Strengthening Alberta’s Clinical Trial Infrastructure with New Funding
EDMONTON, July 7 — A significant investment in clinical trials is set to transform cancer care in Alberta, with the Alberta Cancer…
-
Alberta Cancer Foundation Commits $35 Million to Cancer Clinical Trials
EDMONTON, July 7 — Wendy Beauchesne has spent the last six years at the helm of the Alberta Cancer Foundation, and on…
-
BEYOND-PSA Study Invites 10,000 London Men to Test New Prostate Blood Test
LONDON, July 7 — A charity dedicated to tackling the most common cancer in men is hoping a new fundraising drive will…
-
Campbell Roy to Walk 537 Miles Across Scotland for Prostate Cancer Research
LONDON, July 7 — When Sir Chris Hoy, a six-time Olympic gold medalist and 11-time world champion cyclist, retired from competitive cycling,…
-
Owerko Centre Among Sites Sharing Alberta Cancer Foundation’s $35M Trials Fund
CALGARY, July 7 — A major investment announced yesterday is set to transform how quickly families across Alberta, and potentially beyond, can…
-
Strand Life Sciences Wins Indian Patent for Blood-Based Early Cancer Detection Test
BANGALORE, July 7 — A new patented technology from Strand Life Sciences is changing how doctors look for cancer in its earliest,…
-
Emily Whitehead, First Child Given CAR T Therapy, Cancer-Free More Than Nine Years Later
PHILLIPSBURG, N.J., July 7 — In the long, often heartbreaking history of childhood cancer research, there are a handful of moments that…
-
Motley Fool Columnist Predicts AI Stock Bubble Will Burst, Citing Four Warning Signs
WASHINGTON, July 6 — A new Treasury Department report is warning that the artificial intelligence stock frenzy could end badly for everyday…
-
Treasury’s Office of Financial Research Faces Deep Staff Cuts and Budget Pressure
WASHINGTON, July 6 — The Office of Financial Research has about 300 analysts and economists watching for the next threat to the…
-
Oncologist Explains Why More Indians in Their 30s Are Being Diagnosed With Cancer
NEW DELHI, July 5 — For decades, cancer carried an image of being an illness that arrived late in life. That image…
-
Martin Lewis Warns Holidaymakers Against Buying Foreign Cash at the Airport
CHICAGO, July 5 — A personal finance expert is warning travelers that a common habit at the airport is costing them money,…
-
Melbourne Banker’s Faint Chest Ache Turned Out to Be a Rare, Aggressive Cancer
MELBOURNE, July 5 — A young finance professional who dismissed a strange chest ache as a training strain was later diagnosed with…
-
Millionaire Andrew Tobias Left New York for 25 Years and Now Backs Higher Taxes
NEW YORK, July 5 — The figure that matters: Andrew Tobias is a New York City millionaire, and he will happily pay…
-
History of U.S. Inflation Trends Since 2020
WASHINGTON, July 5 — The United States is entering the second half of 2026 with inflation stubbornly refusing to complete its journey…
-
UK Phase 2 Trial Opens to Test CY-101 in Rare Adrenal Cancer
LONDON, July 5 — A new immunotherapy drug is entering clinical trials for patients with a rare and aggressive adrenal gland cancer…
-
Personalized Vaccine Plus Immunotherapy Shows Promise in Advanced Head and Neck Cancer
NEW YORK, July 5, 2026 — For families facing a cancer diagnosis, the word “immunotherapy” has become a beacon of hope. The…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992